4/A: Eton Pharmaceuticals Director Sells Shares
Insider Transaction (Form 4/A)
Paul Maier V, a Director of Eton Pharmaceuticals, Inc., sold 50,000 shares of common stock on August 28, 2026.
Summary
- Option exercise/conversion: acquired 50,000 Common Stock at $3.78 ($189,000) on August 28, 2026; holds 109,745 after (Direct).
- Open-market sale: disposed of 36,387 Common Stock at $58.64 ($2,133,734) on August 28, 2026; holds 73,358 after (Direct).
- Open-market sale: disposed of 13,485 Common Stock at $60.21 ($811,932) on August 28, 2026; holds 59,873 after (Direct).
- Open-market sale: disposed of 128 Common Stock at $61.77 ($7,907) on August 28, 2026; holds 59,745 after (Direct).
- Option exercise/conversion: acquired 12,500 Common Stock at $7.31 ($91,375) on August 28, 2026; holds 72,245 after (Direct).
- Option exercise/conversion: disposed of 50,000 Employee Stock Option on August 28, 2026 (Direct).
- Option exercise/conversion: acquired 12,500 Employee Stock Option on August 28, 2026 (Direct).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $2,953,572 of stock on the open market.
Insider Transactions
Paul Maier V — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-28 | Option exercise/conversion | Common Stock | 50,000 | $4 | $189.0K | 109,745 |
| 2026-08-28 | Open-market sale | Common Stock | 36,387 | $59 | $2.1M | 73,358 |
| 2026-08-28 | Open-market sale | Common Stock | 13,485 | $60 | $811.9K | 59,873 |
| 2026-08-28 | Open-market sale | Common Stock | 128 | $62 | $7.9K | 59,745 |
| 2026-08-28 | Option exercise/conversion | Common Stock | 12,500 | $7 | $91.4K | 72,245 |
| 2026-08-28 | Option exercise/conversion | Employee Stock Option | 50,000 | — | — | 0 |
| 2026-08-28 | Option exercise/conversion | Employee Stock Option | 12,500 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-28 | Option exercise/conversion (50,000 shares) |
| 2026-08-28 | Open-market sale (36,387 shares) |
| 2026-08-28 | Open-market sale (13,485 shares) |
| 2026-08-28 | Open-market sale (128 shares) |
| 2026-08-28 | Option exercise/conversion (12,500 shares) |
| 2026-08-28 | Option exercise/conversion (50,000 shares) |
| 2026-08-28 | Option exercise/conversion (12,500 shares) |
Keywords
insider transaction, Form 4/A, ETON, Eton Pharmaceuticals, Inc., bearish, Paul Maier V
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.